跳至主要内容
临床试验/NCT01384214
NCT01384214已完成4 期

Pilot Study of the Effect of Botulinum Toxin Type A Treatment on Swallowing in Patients With Cervical Dystonia

Allergan1 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2008年10月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Allergan
入组人数
28
试验地点
1
主要终点
Change from Baseline in Oropharyngeal Swallow Efficiency (OPSE)

研究概览

简要总结

The purpose of this study is to evaluate swallowing efficiency in patients with cervical dystonia following treatment with botulinum toxin Type A.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with cervical dystonia
  • Successfully completed Allergan study MedAff BTX-0616 with 16 weeks since last botulinum toxin Type A injection
  • In need of additional botulinum toxin Type A injections

排除标准

  • Surgery or spinal cord stimulation for cervical dystonia
  • Previous injections of phenol or alcohol for cervical dystonia

结局指标

主要结局

Change from Baseline in Oropharyngeal Swallow Efficiency (OPSE)

时间窗: Baseline, Week 2

次要结局

  • Toronto Western Spasmodic Torticollis Scale (TWSTRS) Total Score(Week 4)
  • Physician Assessment of Cervical Dystonia Severity(Week 4)
  • Global Assessment of Benefit by Physician(Week 4)
  • Global Assessment of Benefit by Patient(Week 4)
  • Patient Visual Analog Assessment of Pain(Week 4)

研究者

发起方
Allergan
申办方类型
Industry

研究点 (1)

Loading locations...

相似试验

Effect of Botulinum Toxin Type A on Swallowing in... | 临床试验